Metastatic Crohn’s disease: Remission induced by mesalamine and prednisone
- 1 September 1999
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 41 (3) , 476-479
- https://doi.org/10.1016/s0190-9622(99)70125-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cutaneous Crohn's disease in childrenJournal of the American Academy of Dermatology, 1997
- Current Medical Therapy for Inflammatory Bowel DiseaseSouthern Medical Journal, 1996
- Mesalamine in Crohn's disease with steroid-induced remission: Effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires DigestivesGastroenterology, 1996
- Maintenance Therapy in Ulcerative Colitis and Crohnʼs DiseaseJournal of Clinical Gastroenterology, 1995
- A Randomized, Double-Blind, Placebo-Controlled Trial of the Oral Mesalamine (5-ASA) Preparation, Asacol, in the Treatment of Symptomatic Crohn??s Colitis and IleocolitisJournal of Clinical Gastroenterology, 1994
- Metastatic Crohnʼs DiseaseJournal of Clinical Gastroenterology, 1993
- Experience with Eudragit-S-Coated Mesalamine (Asacol) in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1993
- Metastatic Crohn's DiseaseArchives of Dermatology, 1990
- Metastatic Crohn's diseasePublished by Elsevier ,1984
- Cutaneous manifestations of Crohn's diseaseJournal of the American Academy of Dermatology, 1981